Left Menu
Development News Edition

Too early to give specific response on COVID-19 vaccine supplies to other countries, says MEA

India on Thursday said that the vaccination process is just starting in the country and it is too early to give a specific response on the COVID-19 vaccine supplies to other countries.

ANI | New Delhi | Updated: 14-01-2021 23:15 IST | Created: 14-01-2021 23:15 IST
Too early to give specific response on COVID-19 vaccine supplies to other countries, says MEA
Anurag Srivastava, Spokesperson of Ministry of External Affairs, speaking at the virtual weekly press briefing. (Photo/ANI). Image Credit: ANI

India on Thursday said that the vaccination process is just starting in the country and it is too early to give a specific response on the COVID-19 vaccine supplies to other countries. Ministry of External Affairs spokesperson Anurag Srivastava said at the regular media briefing that India is still assessing production schedules and availability.

He said Prime Minister Narendra Modi has already stated that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis. "In so far as requests from countries for vaccines from India, you would recall that Prime Minister has already stated that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis," he said.

"As you know, the vaccination process is just starting in India. It is too early to give a specific response on the supplies to other countries as we are still assessing production schedules and availability to take decisions in this regard. This may take some time," he added. He was asked about Brazil's health ministry sending a flight to airlift doses of AstraZeneca vaccine from India and the process to be adopted for export of vaccines.

India has given emergency use authorisation to two COVID-19 vaccines Covishield and Covaxin, both being manufactured in the country. While Covishield has been developed by AstraZeneca and Oxford University, Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with ICMR.

The COVID-19 vaccination drive will start in the country from January 16. (ANI)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

PREVIEW-Olympics-IOC board to mull Tokyo matters - but not cancellation

The Tokyo Olympics will top the agenda when the International Olympic Committees executive board meets on Wednesday - but with the board firmly backing the event, any talk of scrapping it altogether due to the COVID-19 pandemic is highly un...

Official: Troops withdraw from home of Uganda's Bobi Wine

An attorney for Bobi Wine says Ugandan soldiers have withdrawn from the opposition presidential challengers home the day after a judge ruled that his house arrest was unlawful.But attorney George Musisi told The Associated Press that securi...

Home Secy briefs HM Amit Shah on Delhi situation

Union Home Secretary Ajay Bhalla on Tuesday briefed Home Minister Amit Shah about the situation in Delhi where the farmers tractor rally against the agri laws turned violent, officials said.The meeting came after a large number of farmers w...

US STOCKS-Futures subdued ahead of earnings rush, Fed meeting

U.S. stock index futures edged lower on Tuesday as investors refrained from making big bets ahead of a slew of quarterly earnings from companies, while the Federal Reserve kicked off its two-day policy meeting.General Electric Co rose about...

Give Feedback